IGC
IGC Pharma·AMEX
--
--(--)
--
--(--)
5.28 / 10
Netural
IGC Pharma's fundamentals are rated neutral with a score of 5.28. Key positives include a healthy interest-coverage ratio of 42.48%, suggesting strong ability to service debt. However, both total operating revenue and operating revenue are declining year-over-year (-5.50%), which tempers enthusiasm. The stock also trades at a premium valuation (PB-ROE = 2.36), and several asset-based metrics fall short. These factors collectively justify a cautious fundamental view, as the company balances solid liquidity against weak top-line growth.
Analysis Checks(8/10)
Revenue-MV
Value-0.26
Score3/3
Weight17.41%
1M Return10.54%
Value-0.26
Score3/3
Weight17.41%
1M Return10.54%
Days sales outstanding
Value10.34
Score2/3
Weight1.51%
1M Return1.10%
Value10.34
Score2/3
Weight1.51%
1M Return1.10%
Net income-Revenue
Value-0.17
Score2/3
Weight13.89%
1M Return8.45%
Value-0.17
Score2/3
Weight13.89%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value42.48
Score2/3
Weight-1.39%
1M Return-1.11%
Value42.48
Score2/3
Weight-1.39%
1M Return-1.11%
Asset-MV
Value-0.50
Score3/3
Weight25.74%
1M Return13.15%
Value-0.50
Score3/3
Weight25.74%
1M Return13.15%
Total operating revenue (YoY growth rate %)
Value-5.50
Score1/3
Weight-1.02%
1M Return-0.79%
Value-5.50
Score1/3
Weight-1.02%
1M Return-0.79%
Profit-MV
Value0.46
Score2/3
Weight13.88%
1M Return8.45%
Value0.46
Score2/3
Weight13.88%
1M Return8.45%
PB-ROE
Value2.36
Score2/3
Weight17.31%
1M Return9.14%
Value2.36
Score2/3
Weight17.31%
1M Return9.14%
Operating revenue (YoY growth rate %)
Value-5.50
Score1/3
Weight-0.98%
1M Return-0.76%
Value-5.50
Score1/3
Weight-0.98%
1M Return-0.76%
Cash-MV
Value-0.07
Score2/3
Weight13.65%
1M Return8.41%
Value-0.07
Score2/3
Weight13.65%
1M Return8.41%
Revenue-MV
Value-0.26
Score3/3
Weight17.41%
1M Return10.54%
Value-0.26
Score3/3
Weight17.41%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value-5.50
Score1/3
Weight-1.02%
1M Return-0.79%
Value-5.50
Score1/3
Weight-1.02%
1M Return-0.79%
Days sales outstanding
Value10.34
Score2/3
Weight1.51%
1M Return1.10%
Value10.34
Score2/3
Weight1.51%
1M Return1.10%
Profit-MV
Value0.46
Score2/3
Weight13.88%
1M Return8.45%
Value0.46
Score2/3
Weight13.88%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight13.89%
1M Return8.45%
Value-0.17
Score2/3
Weight13.89%
1M Return8.45%
PB-ROE
Value2.36
Score2/3
Weight17.31%
1M Return9.14%
Value2.36
Score2/3
Weight17.31%
1M Return9.14%
Interest coverage ratio (EBIT / Interest expense) (%)
Value42.48
Score2/3
Weight-1.39%
1M Return-1.11%
Value42.48
Score2/3
Weight-1.39%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value-5.50
Score1/3
Weight-0.98%
1M Return-0.76%
Value-5.50
Score1/3
Weight-0.98%
1M Return-0.76%
Asset-MV
Value-0.50
Score3/3
Weight25.74%
1M Return13.15%
Value-0.50
Score3/3
Weight25.74%
1M Return13.15%
Cash-MV
Value-0.07
Score2/3
Weight13.65%
1M Return8.41%
Value-0.07
Score2/3
Weight13.65%
1M Return8.41%
Is IGC undervalued or overvalued?
- IGC scores 5.28/10 on fundamentals and holds a Fair valuation at present. Backed by its -47.43% ROE, -582.82% net margin, -3.72 P/E ratio, 2.97 P/B ratio, and 65.00% earnings growth, these metrics solidify its Netural investment rating.
